Tempus AI (NASDAQ:TEM) Stock Price Down 4.2% – Time to Sell?

Shares of Tempus AI, Inc. (NASDAQ:TEM) were down 4.2% during mid-day trading on Wednesday . The company traded as low as $63.78 and last traded at $63.9820. Approximately 2,057,659 shares were traded during trading, a decline of 64% from the average daily volume of 5,666,156 shares. The stock had previously closed at $66.78.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Tempus AI in a research report on Wednesday, October 8th. Canaccord Genuity Group cut their price target on shares of Tempus AI from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Monday, December 22nd. TD Cowen downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 price target on the stock. in a research note on Tuesday, October 21st. HC Wainwright lowered their price objective on shares of Tempus AI from $98.00 to $89.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Finally, Guggenheim upped their target price on shares of Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, September 26th. Six research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $87.20.

Tempus AI Stock Down 3.4%

The company has a current ratio of 3.28, a quick ratio of 3.12 and a debt-to-equity ratio of 2.45. The firm has a market cap of $11.47 billion, a PE ratio of -54.20 and a beta of 5.22. The business’s 50-day simple moving average is $69.04 and its 200 day simple moving average is $73.72.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.05. The firm had revenue of $334.21 million during the quarter, compared to analysts’ expectations of $328.89 million. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. The company’s revenue was up 84.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.46) EPS. As a group, equities research analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insider Activity at Tempus AI

In other news, EVP Erik Phelps sold 1,302 shares of Tempus AI stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $67.42, for a total value of $87,780.84. Following the transaction, the executive vice president owned 89,280 shares of the company’s stock, valued at $6,019,257.60. The trade was a 1.44% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Ryan Fukushima sold 5,000 shares of the company’s stock in a transaction on Monday, January 5th. The stock was sold at an average price of $64.26, for a total value of $321,300.00. Following the transaction, the chief operating officer directly owned 148,808 shares in the company, valued at approximately $9,562,402.08. The trade was a 3.25% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 932,832 shares of company stock valued at $71,184,024 over the last 90 days. Company insiders own 26.27% of the company’s stock.

Hedge Funds Weigh In On Tempus AI

Several hedge funds have recently modified their holdings of the stock. Cranbrook Wealth Management LLC purchased a new stake in Tempus AI during the 3rd quarter worth approximately $25,000. Concord Wealth Partners raised its holdings in shares of Tempus AI by 308.0% in the second quarter. Concord Wealth Partners now owns 408 shares of the company’s stock worth $26,000 after buying an additional 308 shares during the last quarter. JPL Wealth Management LLC acquired a new stake in shares of Tempus AI during the third quarter worth $26,000. GAMMA Investing LLC acquired a new stake in shares of Tempus AI during the third quarter worth $28,000. Finally, Allworth Financial LP grew its holdings in shares of Tempus AI by 5,000.0% during the second quarter. Allworth Financial LP now owns 459 shares of the company’s stock valued at $29,000 after buying an additional 450 shares during the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.